Trial Profile
Pilot Study: The Effect of Rozerem on Sleep Disturbance After Traumatic Brain Injury
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Ramelteon (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- 15 Apr 2013 Planned end date changed from 1 May 2012 to 1 May 2014 as reported by ClinicalTrials.gov.
- 28 Sep 2010 New trial record